Report period | 2018 | 2019 | 2021 | 2022 |
---|---|---|---|---|
End date of the reporting period | ||||
Capitalization, CN¥ | ||||
Capitalization, $ | ||||
Enterprise Value | ||||
Book Value | ||||
Shareholders Book Value | ||||
Current liabilities | ||||
Noncurrent liabilities | ||||
Total liabilities | ||||
Debt | ||||
Cash and cash equivalents | ||||
Net debt | ||||
Assets | ||||
Total ordinary shares | ||||
Ordinary share price |
Ticker | Name | Type | Nominal value | ISIN | Price |
---|---|---|---|---|---|
1801:HK | Innovent Biologics | Common share | - | KYG4818G1010 | HK$33 |
Company name | Innovent Biologics |
---|---|
Tags | #hong_kong_spb |
Sector | Health Care / Pharmaceuticals, Biotechnology & Life Sciences / Biotechnology / Biotechnology |
Business address | 168 Dongping Street Suzhou Industrial Park Suzhou 215123 China |
Mailing address | 168 Dongping Street Suzhou Industrial Park Suzhou 215123 China |
Website | www.innoventbio.com |